Who
Gary Hattersley
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Nuvation Bio; Chief Scientific Officer, Radius Health.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 7
- Bought
- $0
- Sold
- $6.8M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 17 May 2011
- Last trade
- 19 Aug 2026
- Last filed
- 21 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 19 Aug 2026filed 21 Aug 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $187K100,000 at $1.87 | filing |
| 19 Aug 2026filed 21 Aug 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $709K100,000 at $7.09 | filing |
| 19 Aug 2026filed 21 Aug 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 19 Aug 2026filed 21 Aug 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $187K100,000 at $1.87 | filing |
| 19 Aug 2026filed 21 Aug 2026 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $709K100,000 at $7.09 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 27 Feb 2026filed 3 Mar 2026 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —748,130 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —69,051 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —300,000 at $0.00 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $120K69,051 at $1.74 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $499K69,051 at $7.23 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $582K300,000 at $1.94 | filing |
| 20 Nov 2025filed 24 Nov 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $2.2M300,000 at $7.23 | filing |
| 27 Oct 2025filed 29 Oct 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code M | —100,000 at $0.00 | filing |
| 27 Oct 2025filed 29 Oct 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Code M | $174K100,000 at $1.74 | filing |
| 27 Oct 2025filed 29 Oct 2025 | NUVB Nuvation BioBiotechnology | SEC FORM 4 Sold | $502K100,000 at $5.02 | filing |
| 28 Feb 2025filed 4 Mar 2025 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 29 Feb 2024filed 4 Mar 2024 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 28 Feb 2023filed 2 Mar 2023 | NUVB Nuvation Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
News
Critical Review: Nuvation Bio (NYSE:NUVB) vs. OSR (NASDAQ:OSRH)NUVB · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Gary Hattersley; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.